Dyne Therapeutics (DYN) PT Raised to $35 at RBC Capital
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $17.11 -5.26%
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
RBC Capital analyst Luca Issi raised the price target on Dyne Therapeutics (NASDAQ: DYN) to $35.00 (from $30.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
- China Cinda Asset Management (1359:HK) PT Lowered to HK$0.95 at JPMorgan
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
